Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
OtherConference Proceeding

Broadening Our Expectations for Viral Safety Risk Mitigation

Ivar J. Kljavin
PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 645-653; DOI: https://doi.org/10.5731/pdajpst.2011.00833
Ivar J. Kljavin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 6 645-653
DOI 
https://doi.org/10.5731/pdajpst.2011.00833
PubMed 
22294591

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online January 4, 2012.

Copyright & Usage 
© PDA, Inc. 2011

Author Information

  1. Ivar J. Kljavin
  1. Genentech, Quality Control Virus and Mycoplasma
  1. Ivar J. Kljavin, Genentech, A member of the Roche Group, Quality Control Virus and Mycoplasma. E-mail: kljavin.ivar{at}gene.com.
View Full Text

Cited By...

  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Considerations for risk and control of mycoplasma in bioprocessing
    Phillip Angart, Casey Kohnhorst, Meng-Jung Chiang, Nilou Sarah Arden
    Current Opinion in Chemical Engineering 2018 22
  • Impacts of intentional mycoplasma contamination on CHO cell bioreactor cultures
    Erica J. Fratz‐Berilla, Talia Faison, Casey L. Kohnhorst, Sai Rashmika Velugula‐Yellela, David N. Powers, Kurt Brorson, Cyrus Agarabi
    Biotechnology and Bioengineering 2019 116 12
  • Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events
    Erica J. Fratz‐Berilla, Phillip Angart, Ryan J. Graham, David N. Powers, Adil Mohammad, Casey Kohnhorst, Talia Faison, Sai Rashmika Velugula‐Yellela, Nicholas Trunfio, Cyrus Agarabi
    Biotechnology and Bioengineering 2020 117 9
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 65 (6)
PDA Journal of Pharmaceutical Science and Technology
Vol. 65, Issue 6
November/December 2011
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Broadening Our Expectations for Viral Safety Risk Mitigation
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Broadening Our Expectations for Viral Safety Risk Mitigation
Ivar J. Kljavin
PDA Journal of Pharmaceutical Science and Technology Nov 2011, 65 (6) 645-653; DOI: 10.5731/pdajpst.2011.00833

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Broadening Our Expectations for Viral Safety Risk Mitigation
Ivar J. Kljavin
PDA Journal of Pharmaceutical Science and Technology Nov 2011, 65 (6) 645-653; DOI: 10.5731/pdajpst.2011.00833
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • I. Consider That Virus Contaminations Will Occur—Lessons Learned
    • II. Consider the Risks of Your Raw Materials
    • III. Consider the Limitations of Cell-Based Viral Detection
    • IV. Summary: Consider All Parts of Your Viral Barrier Strategy
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Conference Proceeding

  • Proceedings of the 2017 Viral Clearance Symposium, Session 4: Submission Strategies
  • Proceedings of the 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation
  • Proceedings of the 2017 Viral Clearance Symposium: Conclusion
Show more Conference Proceeding

Plenary Session 5: Viral Testing: Existing Assays and Emerging Technologies

  • Current Testing Methods and Challenges for Detection of Adventitious Viruses
  • Overview of Emerging Technologies To Detect Adventitious Agents
  • Theory and Practice of Conventional Adventitious Virus Testing
Show more Plenary Session 5: Viral Testing: Existing Assays and Emerging Technologies

Paper

  • Current Testing Methods and Challenges for Detection of Adventitious Viruses
  • Overview of Emerging Technologies To Detect Adventitious Agents
  • Theory and Practice of Conventional Adventitious Virus Testing
Show more Paper

Similar Articles

>

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2023 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

Powered by HighWire